• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2-21 世纪的大流行,临床表现-神经学影响。

SARS-COV-2 - the pandemic of the XXI century, clinical manifestations - neurological implications.

机构信息

Department of Neurosurgery, Faculty of Medicine, Lucian Blaga University, Sibiu, Romania.

Department of Neurosurgery, County Emergency Hospital, Sibiu, Romania.

出版信息

J Med Life. 2022 Mar;15(3):319-327. doi: 10.25122/jml-2020-0151.

DOI:10.25122/jml-2020-0151
PMID:35450003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9015186/
Abstract

In December 2019, in Wuhan, China, the first cases of infection with SARS-CoV 2 responsible for COVID-19 disease were identified. SARS-CoV 2 was declared a pandemic on March 11, 2020, and since then has attracted the medical world's attention. The threat to humans' health that this emerging pandemic could leave raises awareness on the importance of understanding the mechanisms that underlie the developing conditions. The epidemiology, clinical picture, and pathogenesis of COVID-19 show that this virus presents new strategies to overcome the past defensive medicine. While all the current data has focused on the pulmonary and cardiovascular manifestations, little has been written about the neurological implications of the disease. This review updates new clinical aspects that SARS-CoV 2 expresses in humans by focusing primarily on neurological manifestations. The damage to the nervous system became more apparent - anosmia, ageusia, polyneuritis, meningitis, meningoencephalitis, stroke, acute necrotizing encephalopathy. Oxygen therapy is vital for those in critical health situations. Finally, prevention is the most important element in breaking the epidemiological chain.

摘要

2019 年 12 月,在中国武汉,首次发现了导致 COVID-19 疾病的 SARS-CoV-2 感染病例。SARS-CoV-2 于 2020 年 3 月 11 日被宣布为大流行,此后引起了医学界的关注。这种新出现的大流行可能对人类健康造成的威胁引起了人们对了解发病机制重要性的认识。COVID-19 的流行病学、临床表现和发病机制表明,这种病毒提出了克服过去防御医学的新策略。虽然所有当前的数据都集中在肺部和心血管表现上,但关于该疾病的神经学影响却很少被提及。这篇综述通过主要关注神经系统表现,更新了 SARS-CoV-2 在人类中表达的新的临床方面。神经系统损伤变得更加明显——嗅觉丧失、味觉丧失、多发性神经炎、脑膜炎、脑膜脑炎、中风、急性坏死性脑病。对于处于危急健康状况的患者,氧疗至关重要。最后,预防是打破流行病学链条的最重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b75b/9015186/1d49a0b51bd1/JMedLife-15-319-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b75b/9015186/49d474f737ce/JMedLife-15-319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b75b/9015186/1d49a0b51bd1/JMedLife-15-319-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b75b/9015186/49d474f737ce/JMedLife-15-319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b75b/9015186/1d49a0b51bd1/JMedLife-15-319-g002.jpg

相似文献

1
SARS-COV-2 - the pandemic of the XXI century, clinical manifestations - neurological implications.SARS-CoV-2-21 世纪的大流行,临床表现-神经学影响。
J Med Life. 2022 Mar;15(3):319-327. doi: 10.25122/jml-2020-0151.
2
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)和 2019 冠状病毒病(COVID-19)相关的神经症状、表现和并发症。
J Neurol. 2021 Sep;268(9):3059-3071. doi: 10.1007/s00415-021-10406-y. Epub 2021 Jan 23.
3
A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.新型冠状病毒感染患者的神经病变综述。
Med Sci Monit. 2021 Jun 19;27:e932962. doi: 10.12659/MSM.932962.
4
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.SARS-CoV-2 的神经入侵、嗜神经性和神经炎症事件:了解 COVID-19 患者的神经表现。
Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28.
5
Neurological Manifestations of COVID-19: A systematic review and current update.新型冠状病毒肺炎的神经系统表现:系统评价和最新进展。
Acta Neurol Scand. 2020 Jul;142(1):14-22. doi: 10.1111/ane.13266. Epub 2020 Jun 2.
6
COVID-19 and Neurology: An Emerging Association.新型冠状病毒肺炎与神经科:新兴关联
Infect Disord Drug Targets. 2021;21(8):e160921191570. doi: 10.2174/1871526521666210218202226.
7
A review of pathophysiology and neuropsychiatric manifestations of COVID-19.COVID-19 的病理生理学和神经精神表现综述。
J Neurol. 2021 Jun;268(6):2007-2012. doi: 10.1007/s00415-020-09950-w. Epub 2020 Jun 3.
8
Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.新型冠状病毒肺炎相关神经系统表现:目前的认识及新冠大流行期间的潜在神经学挑战。
Mol Neurobiol. 2021 Sep;58(9):4694-4715. doi: 10.1007/s12035-021-02450-6. Epub 2021 Jun 24.
9
nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis.2019 年新型冠状病毒感染引起的神经学结局和表现,与其历史祖先 SARS-CoV 和 MERS-CoV 相关:系统评价和荟萃分析。
Sci Rep. 2021 Jun 18;11(1):12888. doi: 10.1038/s41598-021-92188-x.
10
Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.了解 SARS-CoV-2 的神经嗜性特征:从 COVID-19 的神经系统表现到潜在的神经嗜性机制。
J Neurol. 2020 Aug;267(8):2179-2184. doi: 10.1007/s00415-020-09929-7. Epub 2020 May 26.

引用本文的文献

1
Celebrating 70 years of DNA discovery: exploring the Blueprint of Life.庆祝DNA发现70周年:探索生命蓝图。
J Med Life. 2024 Apr;17(4):387-391. doi: 10.25122/jml-2024-1007.
2
Anxiety and Depression Levels and Coping Strategies among Polish Healthcare Workers during the COVID-19 Pandemic.新冠疫情期间波兰医护工作者的焦虑与抑郁水平和应对策略。
Int J Environ Res Public Health. 2023 Feb 14;20(4):3319. doi: 10.3390/ijerph20043319.

本文引用的文献

1
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.新型冠状病毒特异性免疫应答与 COVID-19 发病机制。
Int J Mol Sci. 2022 Feb 2;23(3):1716. doi: 10.3390/ijms23031716.
2
Spectrum of neurological complications following COVID-19 vaccination.接种 COVID-19 疫苗后的神经系统并发症谱。
Neurol Sci. 2022 Jan;43(1):3-40. doi: 10.1007/s10072-021-05662-9. Epub 2021 Oct 31.
3
COVID-19 Vaccine: Side Effects After the First Dose of the Oxford AstraZeneca Vaccine Among Health Professionals in Low-Income Country: Ethiopia.
新冠疫苗:低收入国家埃塞俄比亚卫生专业人员接种第一剂牛津阿斯利康疫苗后的副作用
J Multidiscip Healthc. 2021 Sep 16;14:2577-2585. doi: 10.2147/JMDH.S331140. eCollection 2021.
4
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.辉瑞-BioNTech 疫苗加强针在以色列预防新冠病毒。
N Engl J Med. 2021 Oct 7;385(15):1393-1400. doi: 10.1056/NEJMoa2114255. Epub 2021 Sep 15.
5
Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study.新冠后出现神经系统症状和无神经系统症状患者的自主神经功能障碍:一项前瞻性多领域观察研究。
J Neurol. 2022 Feb;269(2):587-596. doi: 10.1007/s00415-021-10735-y. Epub 2021 Aug 12.
6
Neurological manifestations of COVID-19 - an approach to categories of pathology.新型冠状病毒肺炎的神经学表现——病理学分类方法
Neurol Res Pract. 2021 Jul 26;3(1):39. doi: 10.1186/s42466-021-00138-9.
7
COVID-19-related neuropathology and microglial activation in elderly with and without dementia.COVID-19 相关神经病理学和老年痴呆症与非痴呆症患者的小胶质细胞激活。
Brain Pathol. 2021 Sep;31(5):e12997. doi: 10.1111/bpa.12997. Epub 2021 Jun 18.
8
Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms.患有神经系统症状的新冠病毒疾病(COVID-19)患者中枢神经系统中的不同和自身反应性免疫反应。
Cell Rep Med. 2021 May 18;2(5):100288. doi: 10.1016/j.xcrm.2021.100288. Epub 2021 May 3.
9
Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients.COVID-19 患者的缺血性脑卒中、炎症与血管内皮病变。
Stroke. 2021 Jun;52(6):e233-e238. doi: 10.1161/STROKEAHA.120.031971. Epub 2021 May 10.
10
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.强生(Johnson & Johnson)COVID-19 疫苗安全性监测-美国,2021 年 3 月-4 月。
MMWR Morb Mortal Wkly Rep. 2021 May 7;70(18):680-684. doi: 10.15585/mmwr.mm7018e2.